Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

FDA approves opioid painkiller up to 10 times stronger than fentanyl

Drug has been available intravenously for decades, but soon will be available in hospitals as under-the-tongue tablet

Kristin Hugo
New York
Monday 05 November 2018 18:09 EST
Comments
Video: Magic mushrooms could replace antidepressants within five years, says new psychedelic research centre
Video: Magic mushrooms could replace antidepressants within five years, says new psychedelic research centre (Getty)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The Food and Drug Administration has approved a new treatment using opioid painkiller medicine that is one thousand times as strong as morphine and five to ten times as strong as fentanyl.

The treatment, called Dsuvia, is a pill containing 30 microgrammes of a synthetic opioid called sufentanil, which was approved in 1984 for use in injections. Dsuvia will not be legally available outside of a hospital setting. The FDA published a long statement on their decision to approve the drug in the midst of an opioid crisis.

According to Healthline, Pamela Palmer co-founded the company that created Dsuvia, to address the issue of doctors administering doses of painkillers that were too high. Because the drug is given in tablet form to dissolve under a patient’s tongue, Ms Palmer said it reduced the risk of a doctor over-administering an intravenous drug and accidentally causing their death.

The new treatment makes it easier to take opioid painkillers, and the decision to approve it is a controversial one, as opioids are known for being highly addictive and dangerous. Data suggests that opioids killed nearly 49,000 Americans in 2017, whereas gun violence killed fewer than 39,000. (Most gun violence deaths are suicides.) The US Department of Health and Human Services has declared the opioid epidemic a National Emergency.

Support free-thinking journalism and attend Independent events

Massachusetts senator Ed Markey has criticised the decision to approve the drug, claiming that abusing opioids will be even easier in the form of a tablet.

Although it is only approved for use in hospitals, Mr Markey fears that the drug could end up in recreational markets. He called Dsuvia “a new super-charged painkiller that would only worsen the opioid epidemic”.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in